Safety and Efficacy of Sunitinib for Metastatic Renal Cell Carcinoma in Indian Population: A Tertiary Care Center Experience

Journal Title: New Indian Journal of Surgery - Year 2018, Vol 9, Issue 4

Abstract

Purpose: Our study aims to evaluate the efficacy & safety of targeted therapy (Sunitinib) for metastatic renal cell carcinoma (mRCC) in Indian population. Methods: The hospital records of total ninety four patients were reviewed retrospectively in this study who were offered sunitinib for mRCC between 2008 to 2015. Out of ninety four patients 16 pateints (neo-adjuvant cases) were excluded and 78 were included in this study. All patients received Tyrosine kinase inhibitor, sunitinib therapy (50 mg OD, 4/2 scheme). All 39 patients underwent radical nephrectomy prior to initiation of sunitinib therapy. Patients were followed up every cycle for their clinical symptoms following sunitinib therapy and at every 3 month with chest Xray, ultra-sonography and bone scan, CT scan (if required). The RECIST criterion was used to evaluate the overall tumor response. Results: The median survival was 28.5 months (range 9.253-47.7) and progression free survival (PFS) was 9.16 months (range 6.08-12.23). Clear cell histology was found in 60 (76.9%) patients, papillary variety in 12 (15.39%) patients, chromophobe type was seen in 2 patients and rest had mixed sarcamatoid papillary and rhabdoid clear cell variety. Forty eight patients (61.5%) had multiple metastases. Most frequent metastasis was seen in lungs in 28 patients (36%) and bone in 24 patients (31%). Metastasis was also seen in draining lymph nodes, adrenal, omentum, skin, liver, brain. Conclusion: In our study, use of sunitinib showed similar outcome to previously published articles. Our study supports the use of sunitinib in metastatic renal cell carcinoma.

Authors and Affiliations

Vashishtha Saurabh

Keywords

Related Articles

A Case of Tuberculosis of the Penis Masquerading as Carcinoma of Penis

Tuberculosis of various parts of the body has been well studied and reported, but tuberculosis of the penis is still a rare entity, the cause of which can be primary or secondary. Here, we present a case of a 74yr old ma...

Foot Care Practices in Patients with Diabetic Foot Ulcers: A Study in MVJMC & RH

Introduction: Diabetic foot ulcers are the most common cause for prolonged hospitalizations. Though preventable by effective identification, education and preventive foot care practice, we come across plenty cases of dia...

Hyperbaric oxygen therapy: Trends at Prana Hyperbaric Oxygen Therapy Centre Mumbai, India

Background: Hyperbaric Oxygen Therapy (HBO) is an established treatment modality, internationally practiced since a long time ago. International protocols for the practice of hyperbaric oxygen therapy have been establish...

Diabetic Foot Ulcer and Multidrug-Resistant Organisms: Prevalence and Bacteriological Profile

Aim: To study the prevalence and bacteriological profile of multi-drug resistant organism (MDRO) infection in diabetic foot ulcers. Methods: 150 Diabetic patients with foot ulcer were prospectively studied. Detailed cli...

Prospective Study to Compare Laparoscopic Total Extra Peritoneal Repair (TEP) and Lichtenstein’s Mesh Repair (LR) for Inguinal Hernias

Background: The present study is designed to compare laparoscopic total extra peritoneal repair and Lichtenstein’s mesh repair For Inguinal Hernias, in terms of duration of operation, post operative pain, Intraoperative...

Download PDF file
  • EP ID EP548063
  • DOI 10.21088/nijs.0976.4747.9418.5
  • Views 80
  • Downloads 0

How To Cite

Vashishtha Saurabh (2018). Safety and Efficacy of Sunitinib for Metastatic Renal Cell Carcinoma in Indian Population: A Tertiary Care Center Experience. New Indian Journal of Surgery, 9(4), 428-432. https://europub.co.uk/articles/-A-548063